BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12416262)

  • 1. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
    Hirose M; Yamaguchi T; Kimoto N; Ogawa K; Futakuchi M; Sano M; Shirai T
    Int J Cancer; 1998 Aug; 77(5):773-7. PubMed ID: 9688312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E; Denda A; Ozono S; Takahama M; Akai H; Sasaki Y; Kitayama W; Wakabayashi K; Konishi Y
    Cancer Res; 1998 Jul; 58(14):3028-31. PubMed ID: 9679967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
    Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
    J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
    Kuno T; Hirose Y; Yamada Y; Hata K; Qiang SH; Asano N; Oyama T; Zhi H; Iwasaki T; Kobayashi H; Mori H
    Oncol Rep; 2006 Mar; 15(3):533-8. PubMed ID: 16465408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K; Miyamoto S; Suzuki R; Yasui Y; Ikeda R; Kohno H; Yano M; Tanaka T; Hata K; Suzuki K
    Oncol Rep; 2007 Feb; 17(2):297-304. PubMed ID: 17203164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
    Ogawa K; Hirose M; Sugiura S; Cui L; Imaida K; Ogiso T; Shirai T
    Nutr Cancer; 2001; 40(2):134-9. PubMed ID: 11962248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
    Samma S; Tabata S; Nakatsuji F; Yoshie T; Moriya A; Matsuki H; Watanabe S; Babaya K; Hirao Y; Okajima E
    Gan To Kagaku Ryoho; 1985 Aug; 12(8):1661-8. PubMed ID: 3927848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of catechol on the urinary bladder of rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    La Voie EJ; Shigematsu A; Mu B; Rivenson A; Hoffmann D
    Jpn J Cancer Res; 1985 Apr; 76(4):266-71. PubMed ID: 3924700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of an aromatic retinoic acid analog on urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Murasaki G; Miyata Y; Babaya K; Arai M; Fukushima S; Ito N
    Gan; 1980 Jun; 71(3):333-40. PubMed ID: 7418979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
    Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fukushima S; Shibata M; Tamano S; Ito N; Suzuki E; Okada M
    J Natl Cancer Inst; 1987 Aug; 79(2):263-7. PubMed ID: 3474459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E; Hiramatsu T; Kihoin K; Ijuin M; Hirao Y; Ohara S; Babaya K; Tanaka M; Maruyama Y
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):473-9. PubMed ID: 6820898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis.
    Shibata MA; Hagiwara A; Tamano S; Ono S; Fukushima S
    J Toxicol Environ Health; 1989; 26(3):255-65. PubMed ID: 2926828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
    Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
    Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.